161 related articles for article (PubMed ID: 7524833)
1. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
2. [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers].
Jung F; Koscielny J; Mrowietz C; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Arzneimittelforschung; 1993 Feb; 43(2):99-105. PubMed ID: 7681289
[TBL] [Abstract][Full Text] [Related]
3. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
4. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
5. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
Jung F; Waldhausen P; Spitzer S; Wenzel E
Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
[TBL] [Abstract][Full Text] [Related]
6. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
[TBL] [Abstract][Full Text] [Related]
7. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
[TBL] [Abstract][Full Text] [Related]
8. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
9. [Thrombelastographic coagulation analysis following in vitro and in vivo haemodilution with hydroxyethyl starch (HES)].
Asskali F; Lehmann G; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 May; 37(5):258-66. PubMed ID: 12015682
[TBL] [Abstract][Full Text] [Related]
10. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
11. [[Comparison of hydroxyethyl starch solutions derived from potato and corn starch] ].
Rauch S; Sefrin P
Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Dec; 35(12):750-5. PubMed ID: 11194516
[TBL] [Abstract][Full Text] [Related]
12. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
13. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma.
Volopich S; Mosing M; Auer U; Nell B
Vet Ophthalmol; 2006; 9(4):239-44. PubMed ID: 16771759
[TBL] [Abstract][Full Text] [Related]
15. [Hydroxyethyl starch--an interim report].
Weidhase R; Faude K; Weidhase R
Anaesthesiol Reanim; 1998; 23(1):4-14. PubMed ID: 9553245
[TBL] [Abstract][Full Text] [Related]
16. [Acetyl starch as volume substitute, a possible alternative to HES].
Asskali F; Warnken U; Förster H
Dtsch Med Wochenschr; 2001 Jan; 126(1-2):1-6. PubMed ID: 11200658
[TBL] [Abstract][Full Text] [Related]
17. [Effect of an infusion with middle molecular weight hydroxyethyl starch (HAES-steril 10%) on the flow properties of blood in healthy probands].
Landgraf H; Ehrly AM; Saeger-Lorenz K; Vogel C
Infusionsther Klin Ernahr; 1981 Aug; 8(4):200-4. PubMed ID: 6168586
[TBL] [Abstract][Full Text] [Related]
18. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
[TBL] [Abstract][Full Text] [Related]
19. Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes.
Cabrales P; Tsai AG; Intaglietta M
Shock; 2007 Oct; 28(4):461-7. PubMed ID: 17558350
[TBL] [Abstract][Full Text] [Related]
20. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
